USPTO Publishes Three RNAi-Related Patent Applications | GenomeWeb

Title: Therapeutic RNAi Agents for Treating Psoriasis

Number: 20060115455

Filed: Oct. 21, 2005

Lead Inventor: Ken Reed, Benitec

According to the patent application's abstract, the invention "provides compositions and methods suitable for delivering RNAi agents against genetic targets in skin tissues so as to treat psoriasis."


Title: Therapeutic RNAi Agents for Treating Restenosis

Number: 20060115454

Filed: Oct. 14, 2005

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.